Blackcrane Capital’s Axonics, Inc. Common Stock AXNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-46,716
Closed -$2.62M 11
2021
Q4
$2.62M Buy
46,716
+1,617
+4% +$98.8K 3.63% 8
2021
Q3
$2.94M Sell
45,099
-10,710
-19% -$731K 3.74% 10
2021
Q2
$3.54M Sell
55,809
-11,187
-17% -$660K 4.32% 8
2021
Q1
$4.01M Sell
66,996
-57,740
-46% -$3.14M 6.32% 7
2020
Q4
$6.23M Sell
124,736
-51
-0% -$2.39K 12.23% 5
2020
Q3
$6.37M Sell
124,787
-303,572
-71% -$12.7M 14.86% 3
2020
Q2
$15M Sell
428,359
-321,980
-43% -$11.1M 17.01% 3
2020
Q1
$19.1M Buy
750,339
+299,339
+66% +$8.9M 17.43% 2
2019
Q4
$12.5M Buy
+451,000
New +$10.8M 9.97% 5

Other funds holding AXNX

Blackcrane Capital's AXNX Position: Q1 2022 in Review

Blackcrane Capital sold out of Axonics, Inc. Common Stock (AXNX) in Q1 2022, closing a stake of 46,716 shares — an estimated $2.62M sold.

Blackcrane Capital first reported a position in AXNX in Q4 2019 and held it in 9 quarters. The position peaked at $19.1M in Q1 2020. 186 funds tracked by Wall St. Rank hold AXNX as of Q1 2022.

  • Blackcrane Capital reported no remaining Axonics, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Blackcrane Capital sold 46,716 Axonics, Inc. Common Stock shares in Q1 2022, an estimated $2.62M.
  • Blackcrane Capital first reported a position in Axonics, Inc. Common Stock in Q4 2019 and held it in 9 quarters.
  • Blackcrane Capital's Axonics, Inc. Common Stock position peaked at $19.1M in Q1 2020.
  • 186 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q1 2022.

Based on Blackcrane Capital's 13F filing for Q1 2022, filed 12 May 2022.